Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Chembiochem : a European Journal of Chemical Biology
|
January 11, 2021
Strategies for Site-Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags
Philipp Wolf, Georgina Gavins, Annette G Beck-Sickinger, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 2017
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737
Theresa Noll, Susanne Schultze-Seemann, Irina Kuckuck, et al.
AAPS Pharmscitech
|
January 25, 2017
Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment
Yunyun Di, Shaoping Ji, Philipp Wolf, et al.
Anticancer Research
|
March 2, 2018
Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells
Marta Michalska, Susanne Schultze-Seemann, Irina Kuckuck, et al.
Toxins
|
December 2, 2020
Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
Alexandra Fischer, Isis Wolf, Hendrik Fuchs, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
September 13, 2014
Evaluation of a novel algorithm for primary mass casualty triage by paramedics in a physician manned EMS system: a dummy based trial
Philipp Wolf, Marc Bigalke, Bernhard M Graf, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
April 29, 2018
Primary mass casualty incident triage: evidence for the benefit of yearly brief re-training from a simulation study
Michael S Dittmar, Philipp Wolf, Marc Bigalke, et al.
Anticancer Research
|
October 15, 2010
Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer
Patrick Bühler, David Wetterauer, Dorothee Gierschner, et al.
Oncotarget
|
March 13, 2016
In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer
Marta Michalska, Susanne Schultze-Seemann, Lioudmila Bogatyreva, et al.
The Journal of Urology
|
June 11, 2005
Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract
Ursula Elsässer-Beile, Christian Leiber, Philipp Wolf, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Chembiochem : a European Journal of Chemical Biology
|
January 11, 2021
Strategies for Site-Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags
Philipp Wolf, Georgina Gavins, Annette G Beck-Sickinger, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 2017
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737
Theresa Noll, Susanne Schultze-Seemann, Irina Kuckuck, et al.
AAPS Pharmscitech
|
January 25, 2017
Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment
Yunyun Di, Shaoping Ji, Philipp Wolf, et al.
Anticancer Research
|
March 2, 2018
Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells
Marta Michalska, Susanne Schultze-Seemann, Irina Kuckuck, et al.
Toxins
|
December 2, 2020
Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
Alexandra Fischer, Isis Wolf, Hendrik Fuchs, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
September 13, 2014
Evaluation of a novel algorithm for primary mass casualty triage by paramedics in a physician manned EMS system: a dummy based trial
Philipp Wolf, Marc Bigalke, Bernhard M Graf, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
April 29, 2018
Primary mass casualty incident triage: evidence for the benefit of yearly brief re-training from a simulation study
Michael S Dittmar, Philipp Wolf, Marc Bigalke, et al.
Anticancer Research
|
October 15, 2010
Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer
Patrick Bühler, David Wetterauer, Dorothee Gierschner, et al.
Oncotarget
|
March 13, 2016
In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer
Marta Michalska, Susanne Schultze-Seemann, Lioudmila Bogatyreva, et al.
The Journal of Urology
|
June 11, 2005
Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract
Ursula Elsässer-Beile, Christian Leiber, Philipp Wolf, et al.
Page
of 8